Legal & General Group
TSVT

Legal & General Group’s 2seventy bio TSVT Stock Holding History

Legal & General Group’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,345
Closed -$21.5K – 3542
2025
Q1 		$21.5K Hold
4,345
– – ﹤0.01% 2919
2024
Q4 		$12.8K Hold
4,345
– – ﹤0.01% 3191
2024
Q3 		$20.5K Hold
4,345
– – ﹤0.01% 3041
2024
Q2 		$16.7K Sell
4,345
-1,240
-22% -$5.59K ﹤0.01% 3098
2024
Q1 		$29.9K Sell
5,585
-1,577
-22% -$7.42K ﹤0.01% 2858
2023
Q4 		$30.6K Sell
7,162
-19,886
-74% -$61.1K ﹤0.01% 2893
2023
Q3 		$106K Sell
27,048
-13,119
-33% -$86K ﹤0.01% 2823
2023
Q2 		$406K Buy
40,167
+21,199
+112% +$224K ﹤0.01% 2529
2023
Q1 		$193K Buy
18,968
+4,835
+34% +$55.3K ﹤0.01% 2600
2022
Q4 		$132K Buy
14,133
+641
+5% +$9.04K ﹤0.01% 2747
2022
Q3 		$196K Sell
13,492
-9,328
-41% -$138K ﹤0.01% 2638
2022
Q2 		$301K Buy
22,820
+1,566
+7% +$21.3K ﹤0.01% 2493
2022
Q1 		$363K Buy
21,254
+2,744
+15% +$46.5K ﹤0.01% 2484
2021
Q4 		$474K Buy
+18,510
New +$577K ﹤0.01% 2429

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Legal & General Group's TSVT Position: Q2 2025 in Review

Legal & General Group sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 4,345 shares — an estimated $21.5K sold.

Legal & General Group first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $474K in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Legal & General Group reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 4,345 2seventy bio shares in Q2 2025, an estimated $21.5K.
  • Legal & General Group first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Legal & General Group's 2seventy bio position peaked at $474K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.